Wuxi Taxus Pharmaceutical Co., Ltd.

Company Profile
Wuxi Taxus Pharmaceutical Co., Ltd.

Jiangsu Yew Pharmaceutical Co., Ltd was established IN 2006 according to cGMP standard with an investment of USD 22 million, and 80000 square meters construction. It imported the most advanced automatic production line.

The company had planted yew tree for more than 6600 acres, and enlarge the base scale yearly, which is the stable raw material source of Paclitaxel, 10-DAB, Doecetaxle, and so on. It is specialized in antitumor pharmaceutical drug. The company also havs its formulation production line for Paclitaxel, Oxaliplatin etc, which is also GMP factory.

In total it has 180 employees engaged in pharmaceutical industry in the company.

The main APIs products are:

1, Paclitaxle

2, Docetaxle

3, Cabazitaxel

4, 10-Deacetylbaccatin III

5, Side chain

6, allopurinol

7, Demehylcantharidin

8, CyanoTemozomide

9, Ramosetron Hydrochloride

10, Oxaliplatin

Hope that can meet your requirement!

 

Add: Hongdou Industrial park, Donggang Town, Wuxi, China

Contact: Henry Yang  (Director)

Tel: 86-51066865319

E-mail: henry-yang@163.com

more >

Year of Establishment: 2004

Total Assets(USD): choose not to disclose

Total Number of Staff: 150 to 199

Main Competitive Advantages: Brandname,International Approvals/Standards,Experienced R&D Staff

Other Competitive Advantages:

Patents and Copyrights:

Send your message to this supplier
  • From:
  • To:
    Wuxi Taxus Pharmaceutical Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service